Infosys Public Services has been selected by Prime Therapeutics LLC (Prime Therapeutics) to set up a testing centre of excellence (COE) and consolidate the delivery of its application testing services as part of a new three-year contract.
“We look forward to bringing our deep experience in the healthcare industry and pharmacy benefit management in particular as well as globally benchmarked QA and testing service delivery to Prime Therapeutics,” said Eric Paternoster, President & CEO, Infosys Public Services, Inc. “This agreement will allow us to help the company sharpen its focus on providing better care and services to their members.”
“The rapidly-evolving healthcare industry demands faster response and improved information technology quality to ensure Prime Therapeutics’ competitiveness,” said Jim Graham, Vice- President – Application Development, Prime Therapeutics. “Transforming our testing and QA services will help us achieve that and better meet the needs of health plans, employers, and government programmes.”
Prime Therapeutics will streamline and optimize its quality assurance (QA) and testing services as well as enhance its competitiveness with Infosys Public Services’ expertise and world-class delivery model. Prime Therapeutics also expects to expand the capabilities of its QA organization and gain efficiencies in managing a large-scale QA department.
Image Gallery
Infosys to set up Testing COE for Prime Therapeutics LLC
